
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Re-Examining the Role of TNF in MS Pathogenesis and Therapy
Diego Fresegna, Silvia Bullitta, Alessandra Musella, et al.
Cells (2020) Vol. 9, Iss. 10, pp. 2290-2290
Open Access | Times Cited: 78
Diego Fresegna, Silvia Bullitta, Alessandra Musella, et al.
Cells (2020) Vol. 9, Iss. 10, pp. 2290-2290
Open Access | Times Cited: 78
Showing 1-25 of 78 citing articles:
Autoreactive lymphocytes in multiple sclerosis: Pathogenesis and treatment target
Rongzeng Liu, Shushu Du, Lili Zhao, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 79
Rongzeng Liu, Shushu Du, Lili Zhao, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 79
Role of tumor necrosis factor-alpha in the central nervous system: a focus on autoimmune disorders
Natalia Gonzalez Caldito
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 72
Natalia Gonzalez Caldito
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 72
Exploring TNFR1: from discovery to targeted therapy development
Yingying Li, Ruiwei Ye, Haorui Dai, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Yingying Li, Ruiwei Ye, Haorui Dai, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Psoriasis as an Immune-Mediated and Inflammatory Systemic Disease: From Pathophysiology to Novel Therapeutic Approaches
Anna Campanati, Andrea Marani, Emanuela Martina, et al.
Biomedicines (2021) Vol. 9, Iss. 11, pp. 1511-1511
Open Access | Times Cited: 79
Anna Campanati, Andrea Marani, Emanuela Martina, et al.
Biomedicines (2021) Vol. 9, Iss. 11, pp. 1511-1511
Open Access | Times Cited: 79
NF-κB Signaling and Inflammation—Drug Repurposing to Treat Inflammatory Disorders?
Annabell Roberti, Laura Elizabeth Chaffey, David R. Greaves
Biology (2022) Vol. 11, Iss. 3, pp. 372-372
Open Access | Times Cited: 49
Annabell Roberti, Laura Elizabeth Chaffey, David R. Greaves
Biology (2022) Vol. 11, Iss. 3, pp. 372-372
Open Access | Times Cited: 49
ABCB1 and ABCG2 Regulation at the Blood-Brain Barrier: Potential New Targets to Improve Brain Drug Delivery
J Schulz, Anika M. S. Hartz, Björn Bauer
Pharmacological Reviews (2023) Vol. 75, Iss. 5, pp. 815-853
Open Access | Times Cited: 34
J Schulz, Anika M. S. Hartz, Björn Bauer
Pharmacological Reviews (2023) Vol. 75, Iss. 5, pp. 815-853
Open Access | Times Cited: 34
The Role of TNF-α in Alzheimer’s Disease: A Narrative Review
Domenico Plantone, Matteo Pardini, Delia Righi, et al.
Cells (2023) Vol. 13, Iss. 1, pp. 54-54
Open Access | Times Cited: 31
Domenico Plantone, Matteo Pardini, Delia Righi, et al.
Cells (2023) Vol. 13, Iss. 1, pp. 54-54
Open Access | Times Cited: 31
Immune System Dysregulation in the Progression of Multiple Sclerosis: Molecular Insights and Therapeutic Implications
Zuber Khan, Sidharth Mehan, Ghanshyam Das Gupta, et al.
Neuroscience (2024) Vol. 548, pp. 9-26
Closed Access | Times Cited: 13
Zuber Khan, Sidharth Mehan, Ghanshyam Das Gupta, et al.
Neuroscience (2024) Vol. 548, pp. 9-26
Closed Access | Times Cited: 13
Exploring Neutrophil Heterogeneity and Plasticity in Health and Disease
Conny Gysemans, Mateson Beya, E.A. Pedace, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 597-597
Open Access | Times Cited: 1
Conny Gysemans, Mateson Beya, E.A. Pedace, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 597-597
Open Access | Times Cited: 1
Multi-omic evaluation of metabolic alterations in multiple sclerosis identifies shifts in aromatic amino acid metabolism
Kathryn C. Fitzgerald, Matthew D. Smith, Sol Kim, et al.
Cell Reports Medicine (2021) Vol. 2, Iss. 10, pp. 100424-100424
Open Access | Times Cited: 55
Kathryn C. Fitzgerald, Matthew D. Smith, Sol Kim, et al.
Cell Reports Medicine (2021) Vol. 2, Iss. 10, pp. 100424-100424
Open Access | Times Cited: 55
Microglial Pruning: Relevance for Synaptic Dysfunction in Multiple Sclerosis and Related Experimental Models
Maria Concetta Geloso, Nadia D’Ambrosi
Cells (2021) Vol. 10, Iss. 3, pp. 686-686
Open Access | Times Cited: 49
Maria Concetta Geloso, Nadia D’Ambrosi
Cells (2021) Vol. 10, Iss. 3, pp. 686-686
Open Access | Times Cited: 49
Tumor Necrosis Factor-α: The Next Marker of Stroke
Yimeng Xue, Xianwei Zeng, Wen‐Jun Tu, et al.
Disease Markers (2022) Vol. 2022, pp. 1-8
Open Access | Times Cited: 34
Yimeng Xue, Xianwei Zeng, Wen‐Jun Tu, et al.
Disease Markers (2022) Vol. 2022, pp. 1-8
Open Access | Times Cited: 34
Neutrophils in Inflammatory Diseases: Unraveling the Impact of Their Derived Molecules and Heterogeneity
Bushra Riaz, Seonghyang Sohn
Cells (2023) Vol. 12, Iss. 22, pp. 2621-2621
Open Access | Times Cited: 19
Bushra Riaz, Seonghyang Sohn
Cells (2023) Vol. 12, Iss. 22, pp. 2621-2621
Open Access | Times Cited: 19
The role of miRNAs in multiple sclerosis pathogenesis, diagnosis, and therapeutic resistance
Ahmed S. Doghish, Ola Elazazy, Hend H. Mohamed, et al.
Pathology - Research and Practice (2023) Vol. 251, pp. 154880-154880
Closed Access | Times Cited: 16
Ahmed S. Doghish, Ola Elazazy, Hend H. Mohamed, et al.
Pathology - Research and Practice (2023) Vol. 251, pp. 154880-154880
Closed Access | Times Cited: 16
Glial Cells as Key Regulators in Neuroinflammatory Mechanisms Associated with Multiple Sclerosis
Styliani Theophanous, Irene Sargiannidou, Kleopas A. Kleopa
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9588-9588
Open Access | Times Cited: 7
Styliani Theophanous, Irene Sargiannidou, Kleopas A. Kleopa
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9588-9588
Open Access | Times Cited: 7
The relevance of BDNF for neuroprotection and neuroplasticity in multiple sclerosis
Michelle Maiworm
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 6
Michelle Maiworm
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 6
Synthesis and Comprehensive in Vivo Activity Profiling of Olean-12-en-28-ol, 3β-Pentacosanoate in Experimental Autoimmune Encephalomyelitis: A Natural Remyelinating and Anti-Inflammatory Agent
Halil Şenol, Özden Özgün, Aydan Dağ, et al.
Journal of Natural Products (2023) Vol. 86, Iss. 1, pp. 103-118
Open Access | Times Cited: 15
Halil Şenol, Özden Özgün, Aydan Dağ, et al.
Journal of Natural Products (2023) Vol. 86, Iss. 1, pp. 103-118
Open Access | Times Cited: 15
The contribution of tumor necrosis factor to multiple sclerosis: a possible role in progression independent of relapse?
Valentina Mazziotti, Francesco Crescenzo, Ermanna Turano, et al.
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 5
Valentina Mazziotti, Francesco Crescenzo, Ermanna Turano, et al.
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 5
Comparison of the Intestinal Microbiome of Italian Patients with Multiple Sclerosis and Their Household Relatives
Paola Galluzzo, Fanny Claire Capri, Luca Vecchioni, et al.
Life (2021) Vol. 11, Iss. 7, pp. 620-620
Open Access | Times Cited: 28
Paola Galluzzo, Fanny Claire Capri, Luca Vecchioni, et al.
Life (2021) Vol. 11, Iss. 7, pp. 620-620
Open Access | Times Cited: 28
Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: An Expert Delphi Consensus Statement
Maria Concetta Fargnoli, Federico Bardazzi, Luca Bianchi, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 10, pp. 3545-3545
Open Access | Times Cited: 11
Maria Concetta Fargnoli, Federico Bardazzi, Luca Bianchi, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 10, pp. 3545-3545
Open Access | Times Cited: 11
Toward curing neurological autoimmune disorders: Biomarkers, immunological mechanisms, and therapeutic targets
Yahel Segal, John Soltys, Benjamin D. Clarkson, et al.
Neuron (2025)
Closed Access
Yahel Segal, John Soltys, Benjamin D. Clarkson, et al.
Neuron (2025)
Closed Access
Evaluating the Protective Effects of Silymarin Along with a Cholesterol-Supplemented Diet Against Demyelination in an EAE Mouse Model of Multiple Sclerosis: Lipidomic and Inflammatory Aspects
Parvin Mosaddeghi, Seyed Alireza Mesbah‐Namin, Mohammad Javan
Molecular Neurobiology (2025)
Closed Access
Parvin Mosaddeghi, Seyed Alireza Mesbah‐Namin, Mohammad Javan
Molecular Neurobiology (2025)
Closed Access
Comprehensive Update on Multiple Sclerosis-Associated Uveitis and New Epidemiological Insights from the United Kingdom
Cara Heppell, Anuradhaa Subramanian, Nicola J. Adderley, et al.
Ocular Immunology and Inflammation (2025), pp. 1-13
Closed Access
Cara Heppell, Anuradhaa Subramanian, Nicola J. Adderley, et al.
Ocular Immunology and Inflammation (2025), pp. 1-13
Closed Access
The dichotomic role of single cytokines: Fine-tuning immune responses
Rafael Cardoso Maciel Costa Silva, Leonardo Holanda Travassos, Fabiano Ferreira
Cytokine (2023) Vol. 173, pp. 156408-156408
Closed Access | Times Cited: 10
Rafael Cardoso Maciel Costa Silva, Leonardo Holanda Travassos, Fabiano Ferreira
Cytokine (2023) Vol. 173, pp. 156408-156408
Closed Access | Times Cited: 10
Adaptive and Innate Immunity Are Key Drivers of Age at Onset of Multiple Sclerosis
Elina Misicka, Yunfeng Huang, Stephanie Loomis, et al.
Neurology Genetics (2024) Vol. 10, Iss. 3
Open Access | Times Cited: 3
Elina Misicka, Yunfeng Huang, Stephanie Loomis, et al.
Neurology Genetics (2024) Vol. 10, Iss. 3
Open Access | Times Cited: 3